4.5 Article

Recurrence Patterns and Disease-Free Survival after Resection of Intrahepatic Cholangiocarcinoma: Preoperative and Postoperative Prognostic Models

期刊

JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS
卷 223, 期 3, 页码 493-U251

出版社

ELSEVIER SCIENCE INC
DOI: 10.1016/j.jamcollsurg.2016.05.019

关键词

-

类别

资金

  1. French Association of Hepatobiliary Surgery and Transplantation (ACHBT)
  2. Universite de Bourgogne
  3. NIH/NCI [P30 CA008748]

向作者/读者索取更多资源

BACKGROUND: Liver resection is the most effective treatment for intrahepatic cholangiocarcinoma. Recurrent disease is frequent; however, recurrence patterns are ill-defined and prognostic models are lacking. STUDY DESIGN: A primary cohort of 189 patients who underwent resection for intrahepatic cholangiocarcinoma was used for recurrence patterns analysis within and after 24 months. Based on independent factors for disease-free survival identified in Cox regression analysis, preoperative and postoperative models were developed using a recursive partitioning method. Models were externally validated using a multicenter cohort of 522 resected patients (Association Francaise de Chirurgic intrahepatic cholangiocarcinoma study group). RESULTS: Recurrence within 24 months most often involved the liver (82.7%), and most recurrences after 24 months were strictly extrahepatic (61.1%). In multivariable analysis of the primary cohort, independent preoperative factors for disease-free survival were tumor size and multifocality (based on imaging); tumor size, multifocality, vascular invasion, and lymph node metastases (based on pathology) were independent postoperative factors. The preoperative model allowed patient classification into low-risk and high-risk groups for recurrence. In the validation cohort (n = 522), high-risk patients had a greater likelihood of recurrence (hazard ratio = 2.17; 95% CI, 1.74-2.72; p < 0.001). The postoperative model included tumor size, vascular invasion, and positive nodal disease on pathology and classified patients in low-, intermediate-, and high-risk groups in the primary cohort. As compared with low-risk patients in the validation cohort, intermediate-and high-risk patients were more likely to experience recurrence (hazard ratio = 1.9; 95% CI, 1.41-2.47; p < 0.001 and hazard ratio = 2.99; 95% CI, 2.08-4.31; p < 0.001, respectively). CONCLUSIONS: Recurrence patterns are time dependent. Both models as developed and validated in this study classified patients in distinct recurrence risk groups, which can guide treatment recommendations. (C) 2016 by the American College of Surgeons. Published by Elsevier Inc. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Oncology

Application of Hazard Function to Investigate Recurrence of Intrahepatic Cholangiocarcinoma After Curative-Intent Liver Resection: A Novel Approach to Characterize Recurrence

Laura Alaimo, Zorays Moazzam, Zachary J. Brown, Yutaka Endo, Andrea Ruzzenente, Alfredo Guglielmi, Luca Aldrighetti, Matthew Weiss, Todd W. Bauer, Sorin Alexandrescu, George A. Poultsides, Shishir K. Maithel, Hugo P. Marques, Guillaume Martel, Carlo Pulitano, Feng Shen, Olivier Soubrane, Bas Groot Koerkamp, Itaru Endo, Timothy M. Pawlik

Summary: This study aimed to investigate the patterns of recurrence after surgery for intrahepatic cholangiocarcinoma (ICC) in relation to lymph node status, tumor extension, tumor burden score (TBS), and adjuvant chemotherapy. The results showed that the peak of recurrence typically occurred at 6.6 months after surgery. Among patients with negative lymph nodes, T4-category had a higher peak rate of recurrence compared to other T-categories, while high TBS was associated with an earlier peak of recurrence. Among patients with positive lymph nodes, T2-T4 categories had multiple peaks of recurrence with higher hazard rates during the first 3 years after surgery compared to the T1-category, and high TBS groups had an earlier and higher peak rate of recurrence. The administration of adjuvant chemotherapy was associated with delayed hazard rates of recurrence.

ANNALS OF SURGICAL ONCOLOGY (2023)

Article Gastroenterology & Hepatology

Predictive risk-score model to select patients with intrahepatic cholangiocarcinoma for adjuvant chemotherapy

Yutaka Endo, Zorays Moazzam, Laura Alaimo, Henrique A. Lima, Muhammad M. Munir, Chanza F. Shaikh, Alfredo Guglielmi, Luca Aldrighetti, Matthew Weiss, Todd W. Bauer, Sorin Alexandrescu, George A. Poultsides, Minoru Kitago, Shishir K. Maithel, Hugo P. Marques, Guillaume Martel, Carlo Pulitano, Feng Shen, Francois Cauchy, Bas G. Koerkamp, Itaru Endo, Timothy M. Pawlik

Summary: The study developed a predictive model based on tumor characteristics to help identify which patients may benefit the most from adjuvant chemotherapy after resection of ICC. Results showed that patients receiving AC had a survival benefit in high/medium-risk categories but not in low-risk category.
Article Surgery

Combined Tumor Burden Score and Carbohydrate Antigen 19-9 Grading System to Predict Outcomes Among Patients with Intrahepatic Cholangiocarcinoma

Zorays Moazzam, Laura Alaimo, Yutaka Endo, Henrique A. Lima, Andrea Ruzzenente, Alfredo Guglielmi, Luca Aldrighetti, Matthew Weiss, Todd W. Bauer, Sorin Alexandrescu, George A. Poultsides, Shishir K. Maithel, Hugo P. Marques, Guillaume Martel, Carlo Pulitano, Feng Shen, Francois Cauchy, Bas Groot Koerkamp, Itaru Endo, Jordan Cloyd, Aslam Ejaz, Timothy M. Pawlik

Summary: This study investigated the roles of CA19-9 and TBS in intrahepatic cholangiocarcinoma, and found that both CA19-9 and TBS were associated with overall survival and recurrence. The combined use of CA19-9 and TBS, evaluated by the CTC grading system, can predict prognosis in these patients.

JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS (2023)

Article Multidisciplinary Sciences

Targeted next-generation sequencing has incremental value in the diagnostic work-up of patients with suspect pancreatic masses; a multi-center prospective cross sectional study

Friso Achterberg, Babs G. Sibinga Mulder, Quisette Janssen, Bas Groot A. Koerkamp, Lieke L. Hol, Rutger Quispel, Bert Bonsing, Alexander E. Vahrmeijer, Casper H. J. van Eijck, Daphne Roos, Lars Perk, Erwin van der Harst, Peter-Paul L. O. Coene, Michail Doukas, Frank M. M. Smedts, Mike Kliffen, Marie-Louise F. van Velthuysen, Valeska Terpstra, Arantza Farina Sarasqueta, Hans Morreau, J. Sven D. Mieog

Summary: This study investigates the incremental diagnostic value of Next-Generation Sequencing (NGS) in patients with inconclusive diagnosis, showing that NGS can speed up the diagnostic process, prevent repeated procedures, and significantly change the final diagnosis and treatment plan.

PLOS ONE (2023)

Article Medicine, Research & Experimental

Systemic exposure of floxuridine after hepatic arterial infusion pump chemotherapy with floxuridine in patients with resected colorectal liver metastases

Nikki S. IJzerman, Wills F. Filipe, Peter de Bruijn, Florian E. Buisman, Leni van Doorn, Pascal G. Doornebosch, Jessica J. Holster, Cecile Grootscholten, Dirk J. Gruenhagen, Christian P. E. van Bommel, Marjolein Y. V. Homs, Niels F. M. Kok, Cornelis Verhoef, Bas Groot Koerkamp, Koert F. D. Kuhlmann, Ron H. J. Mathijssen, Stijn L. W. Koolen

Summary: This study aimed to quantify the systemic exposure of floxuridine and found that most patients had low concentrations of floxuridine, which decreased over time, indicating minimal systemic side-effects.

BIOMEDICINE & PHARMACOTHERAPY (2023)

Article Surgery

The PD-ROBOSCORE: A difficulty score for robotic pancreatoduodenectomy

Niccolo Napoli, Concetta Cacace, Emanuele F. Kauffmann, Leia Jones, Michael Ginesini, Cesare Gianfaldoni, Alice Salamone, Fabio Asta, Allegra Ripolli, Armando Di Dato, Olivier R. Busch, Marie L. Cappelle, Ying Jui Chao, Roeland F. de Wilde, Thilo Hackert, Jin-Young Jang, Bas Groot Koerkamp, Wooil Kwon, Daan Lips, Misha D. P. Luyer, Felix Nickel, Olivier Saint-Marc, Yan-Shen Shan, Baiyong Shen, Fabio Vistoli, Marc G. Besselink, Mohammad Abu Hilal, Ugo Boggi

Summary: This study developed a difficulty score for robotic pancreatoduodenectomy, which can predict severe postoperative complications. The score was validated in multiple cohorts and showed good performance in predicting complications. The score also predicted other surgical outcomes and is available online.

SURGERY (2023)

Correction Medicine, Research & Experimental

Prophylactic abdominal drainage or no drainage after distal pancreatectomy (PANDORINA): a study protocol of a binational multicenter randomized controlled trial (vol 23, 809, 2022)

F. L. Vissers, A. Balduzzi, E. A. van Bodegraven, J. van Hilst, S. Festen, M. Abu Hilal, H. J. Asbun, J. S. D. Mieog, B. Groot Koerkamp, O. R. Busch, F. Daams, M. Luyer, M. De Pastena, G. Malleo, G. Marchegiani, J. Klaase, I. Q. Molenaar, R. Salvia, H. C. van Santvoort, M. Stommel, D. Lips, M. Coolsen, C. Bassi, C. van Eijck, M. G. Besselink

TRIALS (2023)

Article Surgery

Predictors and Prognostic Significance of Postoperative Complications for Patients with Intrahepatic Cholangiocarcinoma

Yutaka Endo, Zorays Moazzam, Selamawit Woldesenbet, Henrique Araujo Lima, Laura Alaimo, Muhammad Musaab Munir, Chanza F. Shaikh, Alfredo Guglielmi, Luca Aldrighetti, Matthew Weiss, Todd W. Bauer, Sorin Alexandrescu, George A. Poultsides, Minoru Kitago, Shishir K. Maithel, Hugo P. Marques, Guillaume Martel, Carlo Pulitano, Feng Shen, Francois Cauchy, Bas Groot Koerkamp, Itaru Endo, Timothy M. Pawlik

Summary: The prognostic impact of major postoperative complications (POCs) for intrahepatic cholangiocarcinoma (ICC) remains unclear. This study analyzed the relationship between POCs and outcomes relative to lymph node metastases (LNM) and tumor burden score (TBS). The results showed that the presence of POCs was associated with an increased risk of recurrence and death in low TBS/N0 patients, but not in high TBS and/or N1 patients.

WORLD JOURNAL OF SURGERY (2023)

Article Oncology

Hepatic disease control in patients with intrahepatic cholangiocarcinoma correlates with overall survival

Kevin C. Soares, Joshua S. Jolissaint, Sarah M. McIntyre, Kenneth P. Seier, Mithat Gonen, Carlie Sigel, Naaz Nasar, Andrea Cercek, James J. Harding, Nancy E. Kemeny, Louise C. Connell, Bas Groot Koerkamp, Vinod P. Balachandran, Michael I. D'Angelica, Jeffrey A. Drebin, T. Peter Kingham, Alice C. Wei, William R. Jarnagin

Summary: The role of locoregional therapy versus systemic chemotherapy for unresectable intrahepatic cholangiocarcinoma remains controversial. This study compared overall survival in patients treated with resection, hepatic arterial infusion pump chemotherapy, or systemic chemotherapy, and evaluated the efficacy of locoregional salvage therapy. The findings highlight the importance of hepatic disease control and the potential benefits of liver-directed therapy.

CANCER MEDICINE (2023)

Article Surgery

Ideal Outcome After Pancreatoduodenectomy A Transatlantic Evaluation of a Harmonized Composite Outcome Measure

Simone Augustinus, Tara M. Mackay, Bodil Andersson, Joal D. Beane, Olivier R. Busch, Elizabeth M. Gleeson, Bas G. Koerkamp, Tobias Keck, Hjalmar C. van Santvoort, Bobby Tingstedt, Ulrich F. Wellner, Caroline Williamsson, Marc G. Besselink, Henry A. Pitt

Summary: The study defines and assesses Ideal Outcome in the national or multicenter registries of North America, Germany, the Netherlands, and Sweden. The composite outcome measure, Ideal Outcome, can be used for auditing and comparing outcomes after pancreatoduodenectomy. The observed differences can guide collaborative initiatives to improve the outcomes of pancreatic surgery.

ANNALS OF SURGERY (2023)

Article Oncology

Classification of Intrahepatic Cholangiocarcinoma into Perihilar Versus Peripheral Subtype

Tao Wei, Jianfeng Lu, Xue-Lian Xiao, Matthew Weiss, Irinel Popescu, Hugo P. Marques, Luca Aldrighetti, Shishir K. Maithel, Carlo Pulitano, Todd W. Bauer, Feng Shen, George A. Poultsides, Oliver Soubrane, Guillaume Martel, Bas Groot Koerkamp, Endo Itaru, Yi Lv, Xu-Feng Zhang, Timothy M. Pawlik

Summary: Intrahepatic cholangiocarcinoma (ICC) can be classified into two subtypes based on the anatomical origin of tumors, and these subtypes have distinct clinicopathological features and survival outcomes.

ANNALS OF SURGICAL ONCOLOGY (2023)

Meeting Abstract Oncology

Primary percutaneous stenting above the ampulla for palliative biliary drainage of malignant hilar biliary obstruction.

Stijn Franssen, Lydi M. J. W. Van Driel, Adriaan Moelker, Bas Groot Koerkamp

JOURNAL OF CLINICAL ONCOLOGY (2023)

Article Immunology

B cell immune profiles in dysbiotic vermiform appendixes of pancreatic cancer patients

Eveline E. Vietsch, Diba Latifi, Maaike Verheij, Elise W. A. van der Oost, Roeland F. de Wilde, Roel Haen, Anne Loes van den Boom, Bas Groot Koerkamp, Pascal G. Doornebosch, Victorien M. T. van Verschuer, Ariadne H. A. G. Ooms, Farzana Mohammad, Marcella Willemsen, Joachim G. J. V. Aerts, Ricki T. Krog, Noel F. C. C. de Miranda, Thierry P. P. van den Bosch, Yvonne M. Mueller, Peter D. Katsikis, Casper H. J. van Eijck

Summary: This study analyzed the healthy appendix tissue of PDAC patients and found increased inflammation and cytotoxic activity in the GALT. Additionally, the appendix microbiome of PDAC patients had higher levels of certain pathogenic bacteria and lower levels of commensal bacteria.

FRONTIERS IN IMMUNOLOGY (2023)

Meeting Abstract Endocrinology & Metabolism

Comparison of postoperative textbook outcome between pancreatic neuroendocrine tumor and pancreatic ductal adenocarcinoma - A nationwide retrospective cohort study

J. Chen, S. Augustinus, A. Engelsman, B. Bonsing, Groot B. Koerkamp, C. van Eijck, I de Hingh, S. Bouwense, M. Besselink, Nieveen E. van Dijkum

JOURNAL OF NEUROENDOCRINOLOGY (2023)

暂无数据